And the treatment for metastatic disease is finding Sir Spheres as the cornerstone for metastatic disease to the liver which is a multibillion dollar market yet the entire market cap of SRX is 150 million USD. There is a lot of room for growth.
very positive sirtex and genentech news, page-2
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add SRX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
13.3¢ |
Change
0.003(1.92%) |
Mkt cap ! $56.24M | |||
| Open | High | Low | Value | Volume |
| 13.0¢ | 14.0¢ | 13.0¢ | $148.0K | 1.114M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 548006 | 13.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 14.0¢ | 824793 | 16 |
View Market Depth
| Last trade - 15.50pm 27/06/2024 (20 minute delay) ? |
| SRX (ASX) Chart |